ScholarIQanswers from OpenAlex

Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients

PaperCitations, authors & open-access status

Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients have?

ScholarIQcitation count

Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients has 65 citations in the OpenAlex counts ScholarIQ stores.

When was Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients published?

ScholarIQyear

Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients has 2014 year in the ScholarIQ index.

What is the open-access status of Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients?

ScholarIQoa status

Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients has hybrid oa status in the ScholarIQ index.

What is the DOI of Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients?

ScholarIQdoi

The DOI for Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients is on the source record.

What is the PMID of Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients?

ScholarIQpmid

The PMID for Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients is on the source record.

What is the OpenAlex record for Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients?

ScholarIQopenalex

The OpenAlex for Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial